1. Short title This Act may be cited as the Protect Patient Access to Pharmacies Act . 2. Establishing safeguards to ensure fair market competition for pharmacies in Medicare part D Section 1860D–4(b)(1)(C) of the Social Security Act ( 42 U.S.C. 1395w–104(b)(1)(C) ) is amended by adding at the end the following new clauses: (v) Enforcing any willing provider requirements to support patient choice of pharmacy Not later than September 30, 2024, the Secretary shall require that total payment (including dispensing fees) by a PDP sponsor offering a prescription drug plan or MA organization offering an MA–PD plan for each covered part D drug dispensed to an enrollee by a network pharmacy (including specialty pharmacies (as defined under section 1860D–2(d)(4)(E))), net of any and all price concessions, discounts, fees of any type, incentive payments, or any other form of remuneration, ensures that at a minimum, such payment covers such pharmacy’s costs to acquire and to dispense each covered part D drug so that such pharmacy may have the option to participate as a network provider, which shall include the ability to acquire and dispense covered part D drugs and provide pharmacy services necessary for dispensing such drugs. In carrying out this clause, the Secretary shall— (I) utilize pharmacy acquisition cost data on each type of pharmacy for each covered part D drug (excluding drugs purchased under section 340B of the Public Health Service Act) and cost to dispense data from each type of pharmacy (including pharmacies not otherwise owned, controlled, or affiliated with any other pharmacy, plan, or pharmacy benefit manager); (II) establish payment parameters for each covered part D drug that considers how the drug is dispensed and what pharmacy services are provided by each type of pharmacy to support drug management with the individual for whom the drug is dispensed